|Bid||300.80 x N/A|
|Ask||302.20 x N/A|
|Day's range||294.80 - 305.40|
|52-week range||266.60 - 521.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||55.93|
|Earnings date||09 Dec 2021|
|Forward dividend & yield||0.02 (0.83%)|
|Ex-dividend date||13 Jan 2022|
|1y target est||514.66|
The company saw its shares drop to its lowest since the company floated on the London Stock Exchange a year ago.
The British boots brand fell as much as 15% on the day after it revealed a slowdown in revenue growth in its third quarter.
LONDON (Reuters) -Dr. Martens said revenue growth slowed in its third quarter, hammering its share price, after a drop in its wholesale business as it prioritised scarce inventory for online and retail stores channels. Dr. Martens shares sank 13% to 281 pence in late morning trading, giving it a market capitalisation of 2.82 billion pounds. Earlier this month, the group's biggest shareholder, private equity firm Permira, cut its stake by 6.5% to 36.4%, prompting a selloff.